CG Oncology, Inc. Common stock (CGON)
NASDAQ·Healthcare·Biotechnology
$65.74
-1.62%
Mkt Cap $5.90B
Next Earnings
In 8 daysThu, May 7, 2026
EPS Estimate
-$0.58
7 analysts
Revenue Estimate
$453.03K
Last quarter: beat by +16.39% on EPS, +410.50% on revenue.
EPS — Estimate vs Actual
Mkt Cap
$5.90B
P/E
—
Fwd P/E
—
P/S
1460.48
Rev TTM
—
EPS TTM
-$2.08